ADMA
ADMA Biologics, Inc.$10.85-0.09 (-0.78%)Prev Close$10.93·MCap$2.57B·P/E18.39·Vol2.42M·Yield—
▲
Buys (12M)
1
$217.4K
▼
Sells (12M)
22
$14.50M
◆
Net Activity
Net Seller
$14.28M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at ADMA Biologics, Inc. (ADMA) has been dominated by selling, with 1 insider purchase totaling $217.4K and 22 insider sales totaling $14.50M. The most recent insider transaction was by Grossman Adam S (director, officer: President and CEO), who sold $318.4K worth of shares on Mar 17, 2026. ADMA Biologics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.57B.
ADMA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Grossman Adam S | director, officer: President and CEO | Sell | 21,000 | $15.16 | $318.4K | 2,118,777 |
| Mar 10, 2026 | Kestenberg-Messina Kaitlin M. | officer: COO and SVP, Compliance | Sell | 10,096 | $15.63 | $157.8K | 466,600 |
| Mar 9, 2026 | ELMS STEVE | director | Buy | 14,000 | $15.53 | $217.4K | 2,045,730 |
| Feb 19, 2026 | Grossman Adam S | President and CEO | Sell | 24,793 | $16.32 | $404.6K | 0 |
| Feb 19, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 8,161 | $16.32 | $133.2K | 0 |
| Feb 19, 2026 | Tade Brad L. | CFO and Treasurer | Sell | 6,479 | $16.32 | $105.7K | 0 |
| Feb 17, 2026 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.08 | $337.7K | 0 |
| Dec 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $19.79 | $415.6K | 0 |
| Nov 19, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.00 | $336.0K | 0 |
| Oct 24, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.00 | $336.0K | 0 |
| Sep 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.13 | $338.7K | 0 |
| Aug 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.88 | $354.5K | 0 |
| Jul 30, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,208 | $18.59 | $22.5K | 0 |
| Jul 24, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 3,027 | $17.31 | $52.4K | 0 |
| Jul 24, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 7,123 | $17.31 | $123.3K | 0 |
| Jul 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $18.66 | $391.9K | 0 |
| Jun 26, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 9,838 | $18.40 | $181.0K | 0 |
| Jun 16, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $20.81 | $437.0K | 0 |
| Jun 12, 2025 | ELMS STEVE | Director | Sell | 425,621 | $20.74 | $8.83M | 0 |
| Jun 9, 2025 | Grossman Jerrold B | Director | Sell | 10,000 | $21.31 | $213.1K | 0 |
| Jun 9, 2025 | Guiheen Lawrence P. | Director | Sell | 20,000 | $20.96 | $419.2K | 0 |
| May 21, 2025 | Guiheen Lawrence P. | Director | Sell | 9,000 | $20.29 | $182.6K | 0 |
| May 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $19.45 | $408.4K | 0 |
| Apr 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $21.46 | $450.7K | 0 |
| Apr 1, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 18,920 | $19.42 | $367.4K | 0 |
| Mar 19, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $18.92 | $397.3K | 0 |
| Mar 6, 2025 | Grossman Adam S | President and CEO | Sell | 85,951 | $16.95 | $1.46M | 0 |
| Mar 6, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 12,816 | $16.94 | $217.2K | 0 |
| Feb 26, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 5,280 | $15.78 | $83.3K | 0 |
| Feb 25, 2025 | Grossman Adam S | President and CEO | Sell | 72,885 | $15.70 | $1.14M | 0 |
| Feb 25, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,855 | $15.44 | $28.6K | 0 |
| Jan 30, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 3,355 | $16.10 | $54.0K | 0 |
| Dec 31, 2024 | Grossman Adam S | President and CEO | Sell | 14,343 | $17.15 | $246.0K | 0 |
| Dec 31, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,854 | $17.15 | $31.8K | 0 |
| Nov 22, 2024 | Grossman Adam S | President and CEO | Sell | 48,967 | $21.10 | $1.03M | 0 |
| Nov 22, 2024 | Tade Brad L. | CFO and Treasurer | Sell | 15,000 | $21.15 | $317.3K | 0 |
| Sep 30, 2024 | Grossman Adam S | President and CEO | Sell | 21,752 | $19.99 | $434.8K | 0 |
| Sep 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,647 | $19.99 | $52.9K | 0 |
| Sep 9, 2024 | Guiheen Lawrence P. | Director | Sell | 9,000 | $18.47 | $166.2K | 0 |
| Aug 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 24,150 | $16.90 | $408.1K | 0 |
| Aug 29, 2024 | Grossman Jerrold B | Director | Sell | 136,861 | $17.27 | $2.36M | 0 |
| Aug 26, 2024 | Grossman Adam S | President and CEO | Sell | 626,245 | $17.44 | $10.92M | 0 |
| Aug 23, 2024 | KWON YOUNG | Director | Sell | 60,000 | $18.26 | $1.10M | 0 |
| Jul 24, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,502 | $13.58 | $34.0K | 0 |
| Jun 30, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 21,752 | $11.18 | $243.2K | 0 |
| Jun 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,085 | $11.18 | $23.3K | 0 |
| Jun 14, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 100,000 | $10.72 | $1.07M | 0 |
| Mar 31, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 21,752 | $6.60 | $143.6K | 0 |
| Mar 31, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,085 | $6.60 | $13.8K | 0 |
| Mar 18, 2024 | ELMS STEVE | Director | Sell | 461,716 | $6.07 | $2.80M | 0 |
Showing 1–50 of 86
1 / 2
ADMA Insider Buying Activity
The following table shows recent insider purchases of ADMA Biologics, Inc. (ADMA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | ELMS STEVE | director | Buy | 14,000 | $15.53 | $217.4K | 2,045,730 |
ADMA Insider Selling Activity
The following table shows recent insider sales of ADMA Biologics, Inc. (ADMA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Grossman Adam S | director, officer: President and CEO | Sell | 21,000 | $15.16 | $318.4K | 2,118,777 |
| Mar 10, 2026 | Kestenberg-Messina Kaitlin M. | officer: COO and SVP, Compliance | Sell | 10,096 | $15.63 | $157.8K | 466,600 |
| Feb 19, 2026 | Grossman Adam S | President and CEO | Sell | 24,793 | $16.32 | $404.6K | 0 |
| Feb 19, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 8,161 | $16.32 | $133.2K | 0 |
| Feb 19, 2026 | Tade Brad L. | CFO and Treasurer | Sell | 6,479 | $16.32 | $105.7K | 0 |
| Feb 17, 2026 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.08 | $337.7K | 0 |
| Dec 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $19.79 | $415.6K | 0 |
| Nov 19, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.00 | $336.0K | 0 |
| Oct 24, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.00 | $336.0K | 0 |
| Sep 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.13 | $338.7K | 0 |
| Aug 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $16.88 | $354.5K | 0 |
| Jul 30, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,208 | $18.59 | $22.5K | 0 |
| Jul 24, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 3,027 | $17.31 | $52.4K | 0 |
| Jul 24, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 7,123 | $17.31 | $123.3K | 0 |
| Jul 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $18.66 | $391.9K | 0 |
| Jun 26, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 9,838 | $18.40 | $181.0K | 0 |
| Jun 16, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $20.81 | $437.0K | 0 |
| Jun 12, 2025 | ELMS STEVE | Director | Sell | 425,621 | $20.74 | $8.83M | 0 |
| Jun 9, 2025 | Grossman Jerrold B | Director | Sell | 10,000 | $21.31 | $213.1K | 0 |
| Jun 9, 2025 | Guiheen Lawrence P. | Director | Sell | 20,000 | $20.96 | $419.2K | 0 |
| May 21, 2025 | Guiheen Lawrence P. | Director | Sell | 9,000 | $20.29 | $182.6K | 0 |
| May 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $19.45 | $408.4K | 0 |
| Apr 15, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $21.46 | $450.7K | 0 |
| Apr 1, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 18,920 | $19.42 | $367.4K | 0 |
| Mar 19, 2025 | Grossman Adam S | President and CEO | Sell | 21,000 | $18.92 | $397.3K | 0 |
| Mar 6, 2025 | Grossman Adam S | President and CEO | Sell | 85,951 | $16.95 | $1.46M | 0 |
| Mar 6, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 12,816 | $16.94 | $217.2K | 0 |
| Feb 26, 2025 | Tade Brad L. | CFO and Treasurer | Sell | 5,280 | $15.78 | $83.3K | 0 |
| Feb 25, 2025 | Grossman Adam S | President and CEO | Sell | 72,885 | $15.70 | $1.14M | 0 |
| Feb 25, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,855 | $15.44 | $28.6K | 0 |
| Jan 30, 2025 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 3,355 | $16.10 | $54.0K | 0 |
| Dec 31, 2024 | Grossman Adam S | President and CEO | Sell | 14,343 | $17.15 | $246.0K | 0 |
| Dec 31, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 1,854 | $17.15 | $31.8K | 0 |
| Nov 22, 2024 | Grossman Adam S | President and CEO | Sell | 48,967 | $21.10 | $1.03M | 0 |
| Nov 22, 2024 | Tade Brad L. | CFO and Treasurer | Sell | 15,000 | $21.15 | $317.3K | 0 |
| Sep 30, 2024 | Grossman Adam S | President and CEO | Sell | 21,752 | $19.99 | $434.8K | 0 |
| Sep 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,647 | $19.99 | $52.9K | 0 |
| Sep 9, 2024 | Guiheen Lawrence P. | Director | Sell | 9,000 | $18.47 | $166.2K | 0 |
| Aug 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 24,150 | $16.90 | $408.1K | 0 |
| Aug 29, 2024 | Grossman Jerrold B | Director | Sell | 136,861 | $17.27 | $2.36M | 0 |
| Aug 26, 2024 | Grossman Adam S | President and CEO | Sell | 626,245 | $17.44 | $10.92M | 0 |
| Aug 23, 2024 | KWON YOUNG | Director | Sell | 60,000 | $18.26 | $1.10M | 0 |
| Jul 24, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,502 | $13.58 | $34.0K | 0 |
| Jun 30, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 21,752 | $11.18 | $243.2K | 0 |
| Jun 30, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,085 | $11.18 | $23.3K | 0 |
| Jun 14, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 100,000 | $10.72 | $1.07M | 0 |
| Mar 31, 2024 | Grossman Adam S | President,CEO, and Interim CFO | Sell | 21,752 | $6.60 | $143.6K | 0 |
| Mar 31, 2024 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | 2,085 | $6.60 | $13.8K | 0 |
| Mar 18, 2024 | ELMS STEVE | Director | Sell | 461,716 | $6.07 | $2.80M | 0 |
ADMA Insiders
Similar Stocks to ADMA
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B